All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F25%3A43921573" target="_blank" >RIV/00023752:_____/25:43921573 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/25:43928621 RIV/60461373:22310/25:43932719 RIV/60461373:22330/25:43932719

  • Result on the web

    <a href="https://doi.org/10.1016/j.pnpbp.2025.111439" target="_blank" >https://doi.org/10.1016/j.pnpbp.2025.111439</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.pnpbp.2025.111439" target="_blank" >10.1016/j.pnpbp.2025.111439</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats

  • Original language description

    Baeocystin is a naturally occurring tryptamine-based compound found in various psychoactive mushrooms, including in several species of Psilocybe genus. Due to its structural similarity to psilocybin, which has shown a therapeutic potential in treatment of psychiatric disorders, there is a growing interest in investigating whether baeocystin exhibits comparable effects. This study investigated the pharmacokinetic profile and acute behavioural effects of baeocystin in Wistar rats.Behavioural assessments including locomotor activity and its spatial characteristics (in the open field test) and sensorimotor gating measured by prepulse inhibition were evaluated after subcutaneous administration of 1.25 or 5 mg/kg baeocystin. Pharmacokinetics and brain-serum ratios were analysed after the 5 mg/kg sc. dose.Pharmacokinetics demonstrated that both baeocystin and its metabolite, norpsilocin, have a very limited ability to cross the blood-brain barrier. Consistent with the pharmacokinetic profile, baeocystin had no significant effects on locomotor activity, exploratory behaviour, anxiety-like responses, or sensorimotor gating at doses of either 1.25 or 5 mg/kg.In conclusion, our results suggest that baeocystin has minimal to no behavioural effects in rats, probably due to its poor permeability across the blood-brain barrier. This limited penetration may account for its negligible neurobiological and psychedelic activity.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30103 - Neurosciences (including psychophysiology)

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry

  • ISSN

    0278-5846

  • e-ISSN

    1878-4216

  • Volume of the periodical

    140

  • Issue of the periodical within the volume

    111439

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

    1-8

  • UT code for WoS article

    001535192100001

  • EID of the result in the Scopus database

    2-s2.0-105010301904